BioCentury

8:00 AM GMT, Dec 9, 2002
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Tools & Techniques

Prolysis: In bacteria veritas

Last week's deal with chemistry company Evotec OAI AG will help Prolysis Ltd. leverage its bacterial high throughput screening technology to elbow its way into drug discovery. Prolysis, which was spun out of Oxford University in 1998, uses in vivo bacterial assays

Read the full 428 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.